PR031/#1199 Phase I, Two-Part, Mutlicenter, First-in-human (FIH) Study of TORL-1–23, a Novel Claudin 6 (CLDN6) Targeting Antibody Drug Conjugate (ADC) in Patients with Advanced Solid Tumors
International Journal of Gynecological Cancer（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined